ClinicalTrials.Veeva

Menu

A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

Organon logo

Organon

Status and phase

Completed
Phase 4

Conditions

Asthma

Treatments

Drug: Comparator: placebo / Duration of Treatment: 16 weeks
Drug: MK0476; montelukast sodium/Duration of Treatment: 16 weeks

Study type

Interventional

Funder types

Industry

Identifiers

NCT00140946
2005_057
MK0476-075
0476-075

Details and patient eligibility

About

A study to assess the clinical effect of montelukast sodium with concomitant administration of inhaled budesonide in asthmatic patients.

Enrollment

546 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Males or females between the ages of 18 and 70 with asthma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems